Medical Care
Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Research Report 2025
- Jul 08, 25
- ID: 348928
- Pages: 63
- Figures: 70
- Views: 1
The global market for Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease.
The Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pulmonx
Olympus
Boston Scientific Corporation
Segment by Type
Hot Steam Ablation
Membrane Flap Therapy
Segment by Application
Clinics
Hospitals
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease.
The Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pulmonx
Olympus
Boston Scientific Corporation
Segment by Type
Hot Steam Ablation
Membrane Flap Therapy
Segment by Application
Clinics
Hospitals
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hot Steam Ablation
1.2.3 Membrane Flap Therapy
1.3 Market by Application
1.3.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Perspective (2020-2031)
2.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Growth Trends by Region
2.2.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Historic Market Size by Region (2020-2025)
2.2.3 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Region (2026-2031)
2.3 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Dynamics
2.3.1 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Industry Trends
2.3.2 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Drivers
2.3.3 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Challenges
2.3.4 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Players by Revenue
3.1.1 Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Players by Revenue (2020-2025)
3.1.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Players (2020-2025)
3.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue
3.4 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Concentration Ratio
3.4.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue in 2024
3.5 Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Head office and Area Served
3.6 Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Product and Application
3.7 Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Breakdown Data by Type
4.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Historic Market Size by Type (2020-2025)
4.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Type (2026-2031)
5 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Breakdown Data by Application
5.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Historic Market Size by Application (2020-2025)
5.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)
6.2 North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025)
6.4 North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)
7.2 Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025)
7.4 Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)
8.2 Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2020-2025)
8.4 Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)
9.2 Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025)
9.4 Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)
10.2 Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025)
10.4 Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pulmonx
11.1.1 Pulmonx Company Details
11.1.2 Pulmonx Business Overview
11.1.3 Pulmonx Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Introduction
11.1.4 Pulmonx Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)
11.1.5 Pulmonx Recent Development
11.2 Olympus
11.2.1 Olympus Company Details
11.2.2 Olympus Business Overview
11.2.3 Olympus Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Introduction
11.2.4 Olympus Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)
11.2.5 Olympus Recent Development
11.3 Boston Scientific Corporation
11.3.1 Boston Scientific Corporation Company Details
11.3.2 Boston Scientific Corporation Business Overview
11.3.3 Boston Scientific Corporation Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Introduction
11.3.4 Boston Scientific Corporation Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)
11.3.5 Boston Scientific Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Hot Steam Ablation
1.2.3 Membrane Flap Therapy
1.3 Market by Application
1.3.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Perspective (2020-2031)
2.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Growth Trends by Region
2.2.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Historic Market Size by Region (2020-2025)
2.2.3 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Region (2026-2031)
2.3 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Dynamics
2.3.1 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Industry Trends
2.3.2 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Drivers
2.3.3 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Challenges
2.3.4 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Players by Revenue
3.1.1 Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Players by Revenue (2020-2025)
3.1.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Players (2020-2025)
3.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue
3.4 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Concentration Ratio
3.4.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue in 2024
3.5 Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Head office and Area Served
3.6 Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Product and Application
3.7 Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Breakdown Data by Type
4.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Historic Market Size by Type (2020-2025)
4.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Type (2026-2031)
5 Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Breakdown Data by Application
5.1 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Historic Market Size by Application (2020-2025)
5.2 Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)
6.2 North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025)
6.4 North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)
7.2 Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025)
7.4 Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)
8.2 Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2020-2025)
8.4 Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)
9.2 Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025)
9.4 Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (2020-2031)
10.2 Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025)
10.4 Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pulmonx
11.1.1 Pulmonx Company Details
11.1.2 Pulmonx Business Overview
11.1.3 Pulmonx Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Introduction
11.1.4 Pulmonx Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)
11.1.5 Pulmonx Recent Development
11.2 Olympus
11.2.1 Olympus Company Details
11.2.2 Olympus Business Overview
11.2.3 Olympus Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Introduction
11.2.4 Olympus Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)
11.2.5 Olympus Recent Development
11.3 Boston Scientific Corporation
11.3.1 Boston Scientific Corporation Company Details
11.3.2 Boston Scientific Corporation Business Overview
11.3.3 Boston Scientific Corporation Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Introduction
11.3.4 Boston Scientific Corporation Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)
11.3.5 Boston Scientific Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hot Steam Ablation
Table 3. Key Players of Membrane Flap Therapy
Table 4. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Region (2020-2025)
Table 8. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Region (2026-2031)
Table 10. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Trends
Table 11. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Drivers
Table 12. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Challenges
Table 13. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Restraints
Table 14. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Players (2020-2025)
Table 16. Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease as of 2024)
Table 17. Ranking of Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Headquarters and Area Served
Table 20. Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Product and Application
Table 21. Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2020-2025)
Table 25. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2026-2031)
Table 27. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Application (2020-2025)
Table 29. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Application (2026-2031)
Table 31. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pulmonx Company Details
Table 47. Pulmonx Business Overview
Table 48. Pulmonx Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Product
Table 49. Pulmonx Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025) & (US$ Million)
Table 50. Pulmonx Recent Development
Table 51. Olympus Company Details
Table 52. Olympus Business Overview
Table 53. Olympus Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Product
Table 54. Olympus Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025) & (US$ Million)
Table 55. Olympus Recent Development
Table 56. Boston Scientific Corporation Company Details
Table 57. Boston Scientific Corporation Business Overview
Table 58. Boston Scientific Corporation Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Product
Table 59. Boston Scientific Corporation Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025) & (US$ Million)
Table 60. Boston Scientific Corporation Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
Table 64. Authors List of This Report
List of Figures
Figure 1. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Picture
Figure 2. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Type: 2024 VS 2031
Figure 4. Hot Steam Ablation Features
Figure 5. Membrane Flap Therapy Features
Figure 6. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Application: 2024 VS 2031
Figure 8. Clinics Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Others Case Studies
Figure 11. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Report Years Considered
Figure 12. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Region: 2024 VS 2031
Figure 15. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Players in 2024
Figure 16. Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue in 2024
Figure 18. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Country (2020-2031)
Figure 20. United States Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Country (2020-2031)
Figure 24. Germany Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Region (2020-2031)
Figure 32. China Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Country (2020-2031)
Figure 40. Mexico Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Country (2020-2031)
Figure 44. Turkey Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Pulmonx Revenue Growth Rate in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)
Figure 48. Olympus Revenue Growth Rate in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)
Figure 49. Boston Scientific Corporation Revenue Growth Rate in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Table 1. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Hot Steam Ablation
Table 3. Key Players of Membrane Flap Therapy
Table 4. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Region (2020-2025)
Table 8. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Region (2026-2031)
Table 10. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Trends
Table 11. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Drivers
Table 12. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Challenges
Table 13. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Restraints
Table 14. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Players (2020-2025)
Table 16. Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease as of 2024)
Table 17. Ranking of Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Headquarters and Area Served
Table 20. Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Product and Application
Table 21. Global Key Players of Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2020-2025)
Table 25. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Type (2026-2031)
Table 27. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Application (2020-2025)
Table 29. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue Market Share by Application (2026-2031)
Table 31. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Country (2026-2031) & (US$ Million)
Table 46. Pulmonx Company Details
Table 47. Pulmonx Business Overview
Table 48. Pulmonx Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Product
Table 49. Pulmonx Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025) & (US$ Million)
Table 50. Pulmonx Recent Development
Table 51. Olympus Company Details
Table 52. Olympus Business Overview
Table 53. Olympus Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Product
Table 54. Olympus Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025) & (US$ Million)
Table 55. Olympus Recent Development
Table 56. Boston Scientific Corporation Company Details
Table 57. Boston Scientific Corporation Business Overview
Table 58. Boston Scientific Corporation Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Product
Table 59. Boston Scientific Corporation Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025) & (US$ Million)
Table 60. Boston Scientific Corporation Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
Table 64. Authors List of This Report
List of Figures
Figure 1. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Picture
Figure 2. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Type: 2024 VS 2031
Figure 4. Hot Steam Ablation Features
Figure 5. Membrane Flap Therapy Features
Figure 6. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Application: 2024 VS 2031
Figure 8. Clinics Case Studies
Figure 9. Hospitals Case Studies
Figure 10. Others Case Studies
Figure 11. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Report Years Considered
Figure 12. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Region: 2024 VS 2031
Figure 15. Global Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Players in 2024
Figure 16. Global Top Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Revenue in 2024
Figure 18. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Country (2020-2031)
Figure 20. United States Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Country (2020-2031)
Figure 24. Germany Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Region (2020-2031)
Figure 32. China Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Country (2020-2031)
Figure 40. Mexico Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Share by Country (2020-2031)
Figure 44. Turkey Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Pulmonx Revenue Growth Rate in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)
Figure 48. Olympus Revenue Growth Rate in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)
Figure 49. Boston Scientific Corporation Revenue Growth Rate in Interventional Pulmonary Diseases Related to Chronic Obstructive Pulmonary Disease Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Benzyltrimethylammonium Hydroxide (BTMAH) Market Research Report 2025
Jul 10, 25
Global Allyltrimethylammonium Chloride Market Research Report 2025
Jul 10, 25
Global Calcium Bisglycinate Market Research Report 2025
Jul 10, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232